Vailoces, Gena .
HRN: 09-97-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2024
CEFUROXIME 500MG (TAB)
11/23/2024
11/30/2024
ORAL
500mg
BID
S/P NSD With 2nd Degree Perineal Laceration And Repair
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes